Article
The risk of hemophagocytic lymphohistiocytosis in Hermansky-Pudlak syndrome type 2.
Blood - 11 Apr 2013
Jessen Birthe, Bode Sebastian F N, Ammann Sandra, Chakravorty Subarna, Davies Graham, Diestelhorst Jana, Frei-Jones Melissa, Gahl William A, Gochuico Bernadette R, Griese Matthias, Griffiths Gillian, Janka Gritta, Klein Christoph, Kögl Tamara, Kurnik Karin, Lehmberg Kai, Maul-Pavicic Andrea, Mumford Andrew D, Pace David, Parvaneh Nima, Rezaei Nima, de Saint Basile Geneviève, Schmitt-Graeff Annette, Schwarz Klaus, Karasu Gulsun T, Zieger Barbara, Zur Stadt Udo, Aichele Peter, Ehl Stephan
Abstract excerpt
Genetic disorders of lymphocyte cytotoxicity predispose patients to hemophagocytic lymphohistiocytosis (HLH). Reduced lymphocyte cytotoxicity has been demonstrated in Hermansky-Pudlak syndrome type 2 (HPS2), but only a single patient was reported who developed HLH. Because that patient also carri...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
